CAPROCK Group, Inc.
- SEC CIK
- 0001610769
- Latest filing
- Jul 27, 2026
NTLA holding history
Intellia Therapeutics, Inc. in every 13F filed by CAPROCK Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings
- Shares (Q2 2026)
- 13,786
- Value
- $233.3K
- % of portfolio
- <0.1%
- Quarters held
- 6
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 13,786 | $233.3K | <0.1% | +13,786 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −10,159−100.0% | Sold out | Holders |
| Q4 2025 | 10,159 | $91.3K | <0.1% | −523−4.9% | Reduced | Holders |
| Q3 2025 | 10,682 | $121.3K | <0.1% | – | No prior filing | Holders |
| Q2 2025 | – | – | – | – | Not filed | Holders |
| Q1 2025 | 10,068 | $71.6K | <0.1% | +10,068 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −1,514−100.0% | Sold out | Holders |
| Q3 2021 | 1,514 | $203.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 1,514 | $245.0K | <0.1% | +1,514 | New | Holders |